Activiomics, UCB Collaborate on Cell-Signaling Pathway Activity
December 06, 2010
Activiomics, UCB Collaborate on Cell-Signaling Pathway Activity
Under the technology agreement Activiomics will use its mass spectrometry-based TIQUAS platform to gain insight into the signaling mechanisms of therapeutic antibodies in relevant cell-based systems.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.